SCHEMBL2372480

SCHEMBL2372480

COC(=O)c1nc(OC)c(C(F)(F)F)cc1-n1c(C)ccc1C.COc1nc(C(=O)O)c(-n2c(C)ccc2C)cc1C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CFTR P13569 4/20 0.40
MYC P01106 8/20 0.40
RBP4 P02753 2/20 0.37
HSD17B10 Q99714 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LDHA P00338 1/20 0.35
NOTUM Q6P988 1/20 0.34
GRIA1 P42261 1/20 0.34
GRIA2 P42262 1/20 0.34
GRIA3 P42263 1/20 0.34
GRIA4 P48058 1/20 0.34
ESR1 P03372 1/20 0.34
ALOX15 P16050 1/20 0.34
PTPN7 P35236 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2381481 0.95 CFTR (0.42) CFTRMYCRBP4HSD17B10KDM4E
SCHEMBL2373031 0.94 MYC (0.44) CFTRMYCHSD17B10GRIA1GRIA2
SCHEMBL2371652 0.90 CFTR (0.39) CFTRMYCRBP4HSD17B10KDM4E
SCHEMBL17103826 0.89 CFTR (0.42) CFTRMYCRBP4HSD17B10KDM4E
SCHEMBL22775054 0.88 CFTR (0.48) CFTRMYCRBP4HSD17B10KDM4E
SCHEMBL13518970 0.86 CFTR (0.42) CFTRMYCRBP4HSD17B10KDM4E
SCHEMBL2372871 0.84 CFTR (0.45) CFTRMYCRBP4HSD17B10KDM4E
SCHEMBL14786282 0.82 MYC (0.40) CFTRMYCRBP4HSD17B10KDM4E
SCHEMBL2372372 0.82 MYC (0.43) CFTRMYCRBP4HSD17B10KDM4E
SCHEMBL2383885 0.82 MYC (0.43) CFTRMYCRBP4HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020250116-A1 PYRIDINE AND PYRAZINE DERIVATIVE FOR THE TREATMENT OF CF, COPD, AND BRONCHIECTASIS NOVARTIS AG (CH) 2020-12-17 WO disclosed
EP-2547656-B1 PYRIDINE AND PYRAZINE DERIVATIVE FOR THE TREATMENT OF CF NOVARTIS AG (CH) 2015-09-30 EP disclosed
WO-2013038378-A1 Pyridine amide derivatives NOVARTIS AG (CH) 2013-03-21 WO disclosed
EP-2547656-A1 PYRIDINE AND PYRAZINE DERIVATIVE FOR THE TREATMENT OF CF Novartis AG (CH) 2013-01-23 EP disclosed
WO-2011113894-A1 PYRIDINE AND PYRAZINE DERIVATIVE FOR THE TREATMENT OF CF NOVARTIS AG (CH) 2011-09-22 WO disclosed